The global regulatory affairs market size is expected to reach USD 20.9 billion by 2027 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Rise in drug approvals, label expansions of approved products, along with the presence of Fastrack regulatory pathways are anticipated to facilitate the market growth over the forecast period. Technological advancements in regulatory software and the growing digital transformation in the healthcare industry are also expected to contribute to market growth. In addition, the introduction of Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) is anticipated to not only change the EU regulatory landscape and increase the stringency of regulations but also increase the number of documents required to be created and maintained by companies.
Furthermore, the changes in the Central Administration for Pharmaceutical Affairs (CAPA) scope in Egypt is anticipated to change the medical device registration process in the country. Such changes in local regulations are anticipated to favor market growth. Furthermore, several regulatory changes related to clinical trials, vaccine development, and product approvals, initiated by the global and local regulatory authorities to expedite patient access to Covid-19 treatments and vaccines, are anticipated to positively affect the market growth. Market players are actively involved in the adoption of advanced technologies, strategic collaborations, and mergers & acquisition, to strengthen their market positions and outperform the competition. For instance, in 2020, ICON acquired MedPass, a medical device CRO, reimbursement, and regulatory consultancy firm. This acquisition is aimed at strengthening the medical device and diagnostic research services portfolio of ICON through the addition of new clinical and regulatory capabilities in Europe.
Request a free sample copy or view report summary: Regulatory Affairs Market Report
Regulatory writing and publishing was the leading service segment in 2019 and is projected to retain its dominant position throughout the forecast years
This growth is credited to an increase in the outsourcing of selected regulatory functions by major life sciences companies
The oncology indication segment dominated the market in 2019 and will expand further at a steady CAGR from 2020 to 2027
This growth can be attributed to the rising cancer cases and mortality rate along with the presence of several innovative pipeline products
Grand View Research has segmented the global regulatory affairs market on the basis of service, service provider, company size, categories, product stage, indication, end-use, and region:
Regulatory Affairs Service Outlook (Revenue, USD Million, 2016 - 2027)
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2016 - 2027)
Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2016 - 2027)
Regulatory Affairs Categories Outlook (Revenue, USD Million, 2016 - 2027)
Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2016 - 2027)
Regulatory Affairs Indication Outlook (Revenue, USD Million, 2016 - 2027)
Regulatory Affairs End-use Outlook (Revenue, USD Million, 2016 - 2027)
Medical Device Companies
Regulatory Affairs Regional Outlook (Revenue, USD Million, 2016 - 2027)
List of Key Players of Regulatory Affairs Market
Accell Clinical Research, LLC.
PRA Health Sciences
WuXi AppTec, Inc.
Charles River Laboratories International, Inc.
Parexel International Corporation
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."